← Back to all trials
Not Yet Recruiting
NCT07792369
26DT052; Scaling Busulfan Dose to Body Surface Area in Children
Conditions: Busulfan Pharmacokinetic Analysis, Busulfan Dosing, Hematopoietic Stem Cell Transplant (HSCT), Busulfan, Glutathione
Sex: All
Ages: N/A – 21 Years
Healthy volunteers: No
Phase: PHASE1
Enrollment: 38
Sponsor: Children's Hospital of Philadelphia
Location: Children's Hospital of Philadelphia Philadelphia Pennsylvania
Summary
The goal of this pilot study is to determine if scaling the first busulfan dose to Body Surface Area (BSA) in children with a BSA ≥0.5 m2 and using a BSA-banded dosing table for infants (BSA \
Eligibility Criteria
Inclusion Criteria:
1. Subject age: ≤21 years
2. Body Surface Area (BSA):
1. Group A: BSA ≥0.5 m2
2. Group B: BSA \
Source: ClinicalTrials.gov (NCT07792369). StuddyBuddy aggregates publicly available trial information.
